Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immediate Effects of Self-myofascial Release on Latent Trigger Point Sensitivity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02609412
Recruitment Status : Completed
First Posted : November 20, 2015
Last Update Posted : May 11, 2016
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Dr. Winfried Banzer, Goethe University

Brief Summary:

Latent myofascial trigger points (LMTRP) which impair neuromuscular performance occur in both, patients and asymptomatic subjects. As evidence suggests that LMTRP can transform into active trigger points, therapy seems warranted. Besides other modalities, self-massage using foam rollers (self-myofascial release) has been applied as a treatment. However, there is no data on the efficacy of this method concerning LMTRP. Thus, the present study aims to evaluate the effects of different forms of self-myofascial release on LMTRP pain.

Healthy patients with LMTRP in the calf are randomly allocated to one of three groups: 1) 90s static compression of the most sensitive LMTRP by means of the foam roll, 2) dynamic self-myofascial release rolling back and forth on the calf muscles for 90s using a foam roller, 3) placebo laser acupuncture of the most sensitive LMTRP. All subjects participate in a familiarization session with the foam roller one week prior to treatments. As an outcome, pressure pain threshold is assessed with an algometer. The investigators hypothesize, that static compression can reduce pressure pain of LMTRP more effective than dynamic self-myofascial release. The investigators further expect that placebo treatment will be the least effective method.


Condition or disease Intervention/treatment Phase
Trigger Points Other: Static compression of LMTRP Other: Dynamic self-myofascial release of calf Device: Placebo laser acupuncture of LMTRP Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Study Start Date : May 2015
Actual Primary Completion Date : May 2016
Actual Study Completion Date : May 2016

Arm Intervention/treatment
Experimental: Static compression of LMTRP
static compression of most sensitive LMTRP with the foam roll for 90 seconds
Other: Static compression of LMTRP
Static compression of most sensitive Triggerpoint with a foam roller (Blackroll Inc., Germany).

Experimental: Dynamic self-myofascial release of calf
dynamic self-myofascial release rolling back and forth on the entire calf for 90 seconds with the foam roll
Other: Dynamic self-myofascial release of calf
Dynamic self-massage of the calf with a foam roller (Blackroll Inc., Germany).

Placebo Comparator: Placebo laser acupuncture of LMTRP
placebo laser acupuncture applied on most sensitive LMTRP of the calf, light and acoustic sounds provided, but laser remains switched off, 90 seconds
Device: Placebo laser acupuncture of LMTRP
Used device: Laserneedle System (Laserneedle Systems GmbH, Glienicke/Nordbahn, Germany). Electrodes positioned on skin but device remains switched off.




Primary Outcome Measures :
  1. Change in pressure pain threshold [kg/cm²] assessed by pressure algometer [ Time Frame: Baseline (M1) - 3 minutes (M2) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • at least one diagnosed latent myofascial trigger point in the calf
  • age 18 to 65 years
  • written informed consent

Exclusion Criteria:

  • active myofascial trigger point in the calf
  • regular intake of drugs or within past 48 hours
  • severe psychiatric, neurological, orthopaedic, cardiovascular or endocrine diseases
  • pregnancy or nursing period
  • any condition that negatively influences current quality of life

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02609412


Locations
Layout table for location information
Germany
Goethe University Frankfurt/Main
Frankfurt/Main, Germany, 60488
Sponsors and Collaborators
Goethe University
Investigators
Layout table for investigator information
Principal Investigator: Winfried Banzer, MD, PhD Department of Sports Medicine, Goethe University Frankfurt/Main

Layout table for additonal information
Responsible Party: Prof. Dr. Dr. Winfried Banzer, Head of Department, Goethe University
ClinicalTrials.gov Identifier: NCT02609412    
Other Study ID Numbers: SpM2015-002
First Posted: November 20, 2015    Key Record Dates
Last Update Posted: May 11, 2016
Last Verified: May 2016